Business Segments McKesson Corporation

Stocks

MCK

US58155Q1031

Pharmaceuticals

Market Closed - NYSE 16:00:02 2026-10-07 EDT			5-day change	1st Jan Change
910.33 ^USD	-1.23%		+6.62%	+10.98%

10-07	Leerink Partners Adjusts Price Target on McKesson to $1,070 From $1,030	MT
10-07	Truist Downgrades Option Care Health to Buy From Hold on Heels of Announced Sale to McKesson, CD&R; Adjusts PT to $32.05 From $30	MT

Sales 2026 by Business Segment

Sales 2026 by Geography

Historical Breakdown of Revenue by Business Segments

Operating Income: Breakdown by Business Segment

Geographical Revenue Distribution History

Breakdown by Business Segment (USD)

Fiscal Period: March	2022	2023	2024	2025	2026
Pharmaceutical Product Distribution
North American Pharmaceutical	-	-	-	-	337B
CAPEX	-	-	-	-	-334M
D&A	-	-	-	-	134M
Operating Income	-	-	-	-	3.66B
	-	-	-	-	48.42B
Oncology & Multispecialty	-	-	-	-	48.42B
CAPEX	-	-	-	-	-78M
D&A	-	-	-	-	240M
Operating Income	-	-	-	-	1.15B
Other	-	-	-	-	1.04B
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-10M
D&A	-	-	-	-	4M
Operating Income	-	-	-	-	590M
U.S. Pharmaceutical	212B	241B	279B	328B	-
Total Assets	38.35B	41.79B	46.81B	-	-
CAPEX	-137M	-154M	-193M	-241M	-
D&A	228M	212M	229M	231M	-
Operating Income	2.88B	3.21B	2.79B	4B	-
	-	-	-	-	337B
International	36.34B	20.6B	14.13B	14.72B	-
Total Assets	13.72B	6.23B	6.54B	-	-
CAPEX	-177M	-79M	-75M	-107M	-
D&A	204M	115M	117M	86M	-
Operating Income	-968M	136M	319M	-213M	-
European Pharmaceutical Solutions	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-
U.S. Pharmaceutical and Specialty Solutions	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-
Distribution Solutions	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
Gross Profit	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-
	-	-	-	-	1.04B
Healthcare Equipment Distribution
Medical-Surgical Solutions	11.61B	11.11B	11.31B	11.39B	11.51B
Total Assets	5.83B	5.78B	6.23B	-	-
CAPEX	-74M	-117M	-159M	-163M	-94M
D&A	129M	80M	84M	93M	96M
Operating Income	959M	1.12B	952M	773M	938M
	-	-	-	-	11.51B
Healthcare Industry Software
Prescription Technology Solutions	3.86B	4.39B	4.77B	5.22B	5.8B
Total Assets	3.53B	4.17B	4.38B	-	-
CAPEX	-10M	-35M	-31M	-11M	-4M
D&A	82M	77M	84M	86M	82M
Operating Income	500M	566M	835M	875M	1.04B
Technology Solutions	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
Gross Profit	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-
	-	-	-	-	5.8B
Corporate	-	-	-	11M	-
Total Assets	1.88B	4.35B	3.48B	-	-
CAPEX	-137M	-173M	-229M	-337M	-225M
D&A	117M	124M	121M	140M	173M
Operating Income	-	-	-	-	-931M

Geographical breakdown of sales (USD)

Fiscal Period: March	2022	2023	2024	2025	2026
Foreign	-	-	-	-	-
Total Assets	352M	323M	334M	306M	255M
United States	-	-	-	-	-
Total Assets	2.06B	2.21B	2.48B	2.88B	3.18B